Two groups have announced powerful new generative models that can design new proteins on demand not seen in nature. The explosion in text-to-image AI models like OpenAI’s DALL-E 2—programs trained to ...
For the field of drug development, hitting the right target with atomic precision to achieve therapeutic effect remains the core challenge. While traditional R&D pipelines are dependent on ...
Most of the activities that go on inside cells—the activities that keep us living, breathing, thinking animals—are handled by proteins. They allow cells to communicate with each other, run a cell’s ...
Researchers have developed an artificial intelligence system that can create proteins not found in nature using generative diffusion, the same technology behind popular image-creation platforms such ...
Gero, a biotechnology company developing novel therapeutics for aging and chronic diseases, has released ProtoBind-Diff, a novel masked diffusion language model that generates drug-like molecules for ...
MIT researchers are using artificial intelligence to design new proteins that go beyond those found in nature. They developed machine-learning algorithms that can generate proteins with specific ...
This is the third in a three-part series from Medscape on the impact of AI on drug discovery and development. Part 1 is about AI's role in designing speedier, more effective clinical trials. Part 2 is ...
Protein large language model (LLM) designed to help enterprises accelerate drug development coming to Google Cloud's Vertex AI Model Garden soon; one of the first-of-its-kind in the industry Model API ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results